<DOC>
	<DOCNO>NCT00341302</DOCNO>
	<brief_summary>By end 1999 , estimate 1.2 million child live HIV infection . During 1999 alone , 600,000 child newly infect HIV , mostly less-developed country . Most HIV-infected child infect transmission mother child pregnancy , birth , breast milk . Antiretroviral medication , cesarean section rupture membrane , avoidance breastfeeding way reduce risk transmission . This study determine mother-to-child transmission rate effect infant exposure antiretroviral medication mode delivery . Approximately 180 240 HIV-infected pregnant woman Mexico Argentina enrol first year 5-year study . HIV-infected woman evaluate pregnancy , delivery , 6 month delivery . At visit , history take physical examination give ; blood collect laboratory test . HIV-exposed infant evaluate 6 month age . At 2 visit , history take physical examination give ; blood collect laboratory test ; growth assess .</brief_summary>
	<brief_title>A Prospective , Observational Study HIV-Infected Pregnant Women Their Infants Clinical Sites Latin American Caribbean Countries</brief_title>
	<detailed_description>Prospective cohort study describe characteristic HIV-infected pregnant woman HIV-exposed , uninfected child follow participate Latin American site , characterize adverse event pregnancy postpartum period ( HIV-infected woman ) childhood ( HIV-exposed , uninfected child ) accord receipt of/exposure antiretroviral drug ( ) . The study population comprise HIV-infected pregnant woman HIV-exposed infants/children . HIV-infected Women : The study enrol HIV-infected pregnant woman receive medical care participate clinical site : 1 ) plan deliver clinical site ; 2 ) plan continue postpartum routine medical care 5 year clinical site associate outpatient facility . The Pediatric Cohort consist HIV-exposed , uninfected child bear enrol HIV-infected woman . They follow 5 year . ( HIV-exposed child ultimately determine HIV-infected offer enrollment separate study , eligible . ) In addition , NISDI study use data locally conduct , single-site maternal-child health cohort study Brazil ( enrol HIV-uninfected pregnant woman HIV-unexposed infant ) NISDI analyse benefit make comparison healthy control</detailed_description>
	<criteria>INCLUSION CRITERIA : ( HIVInfected Pregnant Women ) Documentation pregnancy , use one following : Urine HCG pregnancy test ; Serum HCG pregnancy test ; Positive fetal heart tone Doppler ; Ultrasound . Documentation HIV infection , define two follow prior pregnancy : Reactive test HIV antibody ; Positive HIV culture ; Positive HIV DNA PCR ; Positive neutralizable HIV p24 antigen ; Positive qualitative HIV RNA ; Quantitative HIV RNA great equal 1000 copies/ml ; Diagnosis AIDSdefining clinical condition . Willingness intent deliver participate clinical site follow six month postpartum site associate outpatient facility . Willingness ability sign inform consentSubject must age provide legal informed consent define country subject resides . Willingness intent infant follow six month age . Subjects may coenrolled clinical trial treatment prophylaxis HIV infection , opportunistic infection , HIV relate problem . Subjects may reenrolled subsequent pregnancy study . Subjects may enroll prior delivery , include labor . EXCLUSION CRITERIA : ( HIVInfected Pregnant Women ) Failure meet inclusion criterion .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 16, 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Perinatal</keyword>
	<keyword>Transmission</keyword>
	<keyword>Antiretroviral</keyword>
	<keyword>Outcomes</keyword>
</DOC>